Design and mode of function of the light-controlled viral transduction system
German and Chinese bioengineers have used “an adeno-associated viral (AAV) [MORE]
George Church launches gene therapy startup to design safer viral vectors
A bioengineering team at Harvard “has developed a way to [MORE]
Advancing gene therapy
Two beguiling questions have vexed gene therapy from the beginning: how safe and effective are the vectors, and [MORE]
Spherical liposomes are light activated for CRISPR gene therapy
Because liposomes are considered safer than viral vectors for gene delivery, researchers [MORE]
Jude Samulski PhD work in gene therapy improves outcomes for DMD
Duchenne Muscular Dystrophy was one of the early targets for [MORE]
Improved CRISPR Cas9
Off targeting has always been a problem for the otherwise remarkable CRISPR-Cas9 gene editing technology. To improve the [MORE]
Gene therapy via viral vector
Making safe and serviceable viral vectors for gene therapy has many challenges—from empty to overfilled AAV [MORE]
Gene therapy to build muscle and reduce OA
In studying osteoarthritis and obesity, Washington University in St. Louis reports this: “Follistatin [MORE]
Gene therapy for ALS
While it has only been demonstrated in mice, researchers at the University of California-San Diego Medical School [MORE]
Research and development BioOhio
“Bolstered by academic research at Columbus’s Nationwide Children’s Hospital and Cincinnati Children’s Hospital along with public and [MORE]
Single dose gene therapy for cocaine addiction
In an article titled “Systemic Safety of a Recombinant AAV8 Vector for Human Cocaine [MORE]
George M. Church
Scientists at Rejuvenate Bio (San Diego, CA), including Harvard biologist and company founder George Church, have done experiments [MORE]
Adeno-associated virus serotype
Adeno-associated viral vectors are a workhorse for gene transfer protocols. Getting enough AAV for gene therapy however has [MORE]
CRISPR Cas9
Seven years after CRISPR-Cas9 gene editing appeared, clinical trials have begun. The University of Pennsylvania has treated two patients, [MORE]